Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Immunogenicity Study

Known as: IMMUNOGENICITY 
A study that assesses an agent's ability to provoke an immune response (humoral and/or cell-mediated) in the subject.
National Institutes of Health

Related topics

Related topics

2 relations
CDISC SDTM Trial Type TerminologyClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design
The task of epitope discovery and vaccine design is increasingly reliant on bioinformatics analytic tools and access to… Expand
Is this relevant?
Highly Cited
2017
Highly Cited
2017
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Recently, the World Health Organization confirmed 120 new human cases of avian H7N9 influenza in China resulting in 37 deaths… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2017
Highly Cited
2017
Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells
ABSTRACT Extracellular vesicles (EVs) are under evaluation as therapeutics or as vehicles for drug delivery. Preclinical studies… Expand
Is this relevant?
Highly Cited
2016
Highly Cited
2016
Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort.
BACKGROUND AND AIMS Biosimilar infliximab CT-P13 is approved for all indications of the originator product in Europe. Prospective… Expand
  • figure 2
  • figure 4
Is this relevant?
Highly Cited
2016
Highly Cited
2016
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study.
BACKGROUND Three full doses of RTS,S/AS01 malaria vaccine provides partial protection against controlled human malaria parasite… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2016
Highly Cited
2016
Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults.
BACKGROUND An investigational subunit vaccine containing the varicella-zoster virus (VZV) glycoprotein E (gE) and the AS01B… Expand
  • figure 2
  • figure 3
Is this relevant?
Review
2015
Review
2015
Vaccine Adjuvants: from 1920 to 2015 and Beyond
The concept of stimulating the body’s immune response is the basis underlying vaccination. Vaccines act by initiating the innate… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2015
Highly Cited
2015
TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes
Significance The design of effective T-cell vaccines against pathogens and tumor antigens is challenged by the highly inefficient… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2014
Highly Cited
2014
Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine
HPV-023 (NCT00518336; ClinicalTrial.gov) is a long-term follow-up of an initial double-blind, randomized (1:1), placebo… Expand
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.
BACKGROUND The 13-valent pneumococcal conjugate vaccine (PCV13) was licensed to replace the 7-valent pneumococcal conjugate… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE